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Objective: Autosomal recessive nonsyndromic hearing loss (ARNSHL) is a genetically heterogeneous
sensorineural disorder. Alpha-tectorin, which is encoded by the TECTA gene, is a non-collagenous
component of the tectorial membrane in the inner ear defect of which leads to moderate to severe
hearing loss (HL).
Methods: 25 unrelated Iranian multiplex ARNSHL families, negative for GJB2mutations, were recruited in
this study. Clinical inspections including audiometric and otologic examinations ruled out syndromic
forms. Genetic linkage analysis was performed using six short tandem repeat markers closely linked to
DFNB21. Haplotype and LOD score analysis were used to conﬁrm possible linkage. All coding exons of
TECTA were subject to DNA sequencing in the linked family.
Results: A novel homozygous variant (c.734G > A) was found in exon 5 of the TECTA gene in one family
leading to a nonsense mutation (p.W245). It co-segregated with HL in the family. This variant was not
detected in 50 controls. All affected individuals in the family had moderate to severe HL. It full ﬁlled the
criteria of a pathogenic variant.
Conclusion: Our data conﬁrms the phenotype-directed genotyping for DFNB21 deafness against the
typical profound HL phenotype seen in the most families segregating ARNSHL. We recommend mutation
screening of TECTA in ARNSHL families segregating moderate to severe HL phenotype.
© 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Hearing loss (HL) is the most common sensorineural defects
with high genotype and phenotype heterogeneity [1]. According to
the World Health Organization, 360,000,000 individuals world
wide have different range of disabling HL (90% and 10% this pop-
ulation are adults and children respectively) (www.who.int/) [2].
HL is a multifactorial disorder, predominantly induced by genetic or
environmental causes or their interactions [2]. It is estimated that
more than half of the cases with congenital sensorineural HL are
associated with genetic factors [3]. HL can be inherited as auto-
somal dominant (DFNA 20%), recessive (DFNB 80%), mitochondrialearch Center, School of Medicine, S
shtori).
rved.maternally, X and Y-linked (2%) [3e5]. Autosomal recessive non-
syndromic hearing loss (ARNSHL) is the most frequent form of HL
(75e80% of cases), [6]. TECTA (DFNB21) is an important gene
involved in HL. It comprises 23 exons and 7426 bp of DNA on
chromosome 11q22-q24, TECTA encodes the 2156 amino acid that is
one of the major non-collagenous glycoproteins of the tectorial
membrane, a non-cellular matrix overlying the cochlear neuro-
epithelium that lies over stereocilia of the hair cells and is critical
for the mechanical ampliﬁcation and transmission of sound [7,8].
Alpha-tectorin is a large modular glycoprotein that contains three
types of functional domains: an N-terminus entactin-like domain,
four von Willebrand type D (vWFD V1, V2, V3, V4) domains and C-hahrekord University of Medical Sciences, Shahrekord, Iran. Tel.: þ98 381 3335654;
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linked to each other by disulﬁde bridges and interact with another
non-collagenous protein [10]. Mutations of various parts of alpha-
tectorin leads to deafness at different frequencies and lead to
speciﬁc genotypeephenotype correlations [11]. Various mutations
in this gene have been shown to be responsible for both autosomal
dominant (DFNA8/12) [7] and recessive (DFNB21) forms of non-
syndromic HL [12]. Studies on different populations have shown
that alpha-tectorinis among the top 10 genes responsible for
ARNSHL [6,13]. Previous studies have shown that TECTA mutations
account for about 4.13% of ARNSHL among GJB2 negative Iranian
families [6]. TECTA has been shown to be related to moderate to
severe audioproﬁle [14]. Iran has a high frequency (37e38%) of
consanguineous or intra group marriage [15]. On the other hand,
the presence of families with large multiple-affected deaf in-
dividuals has made it suitable for genetic studies [15,16]. In this
study, 25 Iranian families with ARNSHL were analyzed for linkage
to the DFNB21 locus after excluding mutations in GJB2. The speciﬁc
audioproﬁle of the patients was also regarded. A single family was
linked to DFNB21; DNA sequencing of the TECTA gene identiﬁed a
novel mutation in this gene.
2. Material and methods
2.1. Patient recruitment and audiometric evaluation
Twenty ﬁve Iranian families (with 350 individuals that 171 of
themwere affected) and 50 (100 chromosome) ethnically matched
healthy Iranian control individuals which had been ascertained
from Khuzestan province, Southwest of Iran. Families were nega-
tive for GJB2 mutations. This study was approved by the institu-
tional review boards of Tehran University of Medical Sciences (No.
150756) and Ahvaz Jundishapur University of Medical Sciences (U-
91074) and Shahrekord University of Medical Sciences (1394-01-
74-2598). Informed consent was taken from subjects or their par-
ents. Based on the interviews with the adult members of the
families, informational questionnaires were ﬁlled out and pedi-
grees were drawn. All the members the families were sampled for
further molecular studies.
2.2. Auditory testing
Pure tone audiometry (PTA) with air conduction at frequencies
ranging from 250 to 8000 Hz was performed for all affected
members of the families according to standard protocols. Audio-
gram results of all patients were deﬁned using a PTA average at 500,
1000, 2000 Hz: mild for 21e40 dB, moderate for 41e70 dB, severe
for 71e95 dB and profound for >95 dB.
2.3. Molecular analysis
2.3.1. DNA preparation
Genomic DNA was extracted from peripheral blood of allTable 1
Heterozygosity and position of selected markers for the DFNB21 locus.
Marker name HZ (%) Forward primer (5'/ 3') Reverse prim
D11S1774 57 CAAAAAGGCTTGGCGGTT GGGCATTCCC
D11S925 85 TTAGACCATTATGGGGGCAA AGAACCAAG
D11S4089 75 TAATCAAAGGCTGTAGTGAATTGG ATTCCTAGTT
D11S4167 77 TCCCCACCTGCCTGAG TGTTGACCAA
D11S1345 e AGCTAAGATGTGCCACAGTAA TCAGTGCTGA
D11S4094 80 CTCAAAGAACAGCCAGTCA GGAGTCGGG
HZ: Heterozygosity.patients and other available members of the families as well as 50
normal control subjects using a standard phenol chloroform pro-
cedure. DNA quantiﬁcation and quality analyses were performed by
spectrophotometry (UNICO 2100, USA) and agarose gel electro-
phoresis using routine procedures.2.3.2. Genotyping microsatellite markers
Selection of DFNB21 short tandem repeat (STR) markers linked
to TECTA and their primers were selected based on their physical
distance at NCBI map viewer (http://www.ncbi.nlm.nih.gov/
mapview). Markers used in this study included: D11S1774,
D11S925 and, D11S4089 at the upstream of the TECTA gene and
D11S4167, D11S1345 and D11S4094 which were downstream
markers. The heterozygosity of these markers and their positions
relative to this gene is shown in Table 1. Slink value for Ahv-9 family
was calculated using FastSlink (version 2.51) option of EasyLinkage
plus (version 5.05) software. Analysis of two-point and multi-point
LOD scores were done by SuperLink (version 1.5), and GenHunter
(version 2.1r5) options of EasyLinkage (version 5.05), respectively
[17]. Haplotypes for STR markers were reconstructed using Gene-
Hunter and were visualized by Haplopainter software (version
029.5) [18]. For calculations of LOD scores, autosomal recessive
pattern of inheritance, complete penetrance and no phenocopy,
equal recombination for male and female allele frequency of
markers and disease allele frequency of 0.001 were assumed [19].2.3.3. Linkage analysis
The following ampliﬁcation conditions were considered for STR
markers, with some modiﬁcations for each amplicon. Reactions
were carried out in a 25 ml volume containing 10 ml Taq x master
mix red (Ampliqon, Hamburg, Germany), 0.5 ml of each of the
primers (10 pM), 2 ml DNA (50 ng), 10 ml ddH2O. The PCR program
for STR ampliﬁcation was as follows: one cycle of 95 C for 3 min
(initial denaturation), 30 cycles of 94 C for 30 s (denaturation), 58 C
for 30s (annealing), 72 C for 30s (extension) and one cycle for the
ﬁnal extension at 72C for 5 min. The ampliﬁcation products were
analyzed by conventional polyacrylamide gel electrophoresis and
silver staining.2.3.4. DNA sequencing of TECTA
Primers for all the 23 coding exons, exoneintron boundaries,
and promoter of TECTA were designed by primer3ver.0.4.0 (http://
frodo.wi.mit.edu/primer3/) and Oligover.6.7.1.0 (National Bio-
sciences Inc.), (Table 2). Ampliﬁcations of all the exons and the
promoter of TECTA were carried out according to the following
program, with some modiﬁcations for different amplicons: one
cycle of 95 C for 3 min (initial denaturation), 30 cycles of 94 C for
30 s (denaturation), 58 C for 30 s (annealing), 72 C for 30 s
(extension) and one cycle for the ﬁnal extension at 72 C for 5 min.
DNA sequencing of the PCR products were carried out bi-
directionally on an ABI 3730XL automated sequencer (Applied
Biosystems) (Macrogen, South Korea) using the same primers.er (5'/ 3') PCR product size (bp) Physical position (bp)
ATGCTCA 206 120,820,059e120,820,264
GTCGTAAGTCCTG 173 120,828,211e120,828,546
CCCTCATAAACACTG 199 120,989,623e120,989,921
AATGTTGTTATGC 106 122,037,647e122,037,752
GCCCATATAT 237 122,427,077e122,427,313
GAATTTCTAA 196 123,176,594e123,176,789
Table 2
TECTA primers for ampliﬁcation of the promoter and 23 exons.
Promoter/Exon Forward primer (5'/ 3') Reverse primer (5'/ 3') PCR product length (bp)
Promoter CTACAGAACAGGTTAGTGACAT GCCAGAGTAAACAGAACACCA 1192
1 TTTTGATGGTCTTGGGATTAGC AAGTGGGAATATAAGTAAACCTC 355
2 AGGATGAATGACAGGGCAGTA CATGAAATCTCAGAACTTGTCGT 418
3 CATACAGTTAGGCGAATGTCT AACTGACACTCCTTAGCTCTA 486
4e5 GGGGAGTGCAAGTCATGAG CATTACCCAGCGGAGAGAT 817
6 CTAACAGGGTTCTTACGTGGA GAGACAAACAGCAGAACCAGT 627
7 TCTGGAGTGTTGAGTTGCTT TTGGGTCACAAGTCTTAACAA 774
8 CACTCTAGGAACTAAATGATCCA TTCTAAAATCCACTCATAGGCAG 809
9 TCGGTTGGTATCTTTGTGGGTT AGGACACATCAGACTAGGGTA 869
10 CCGTCTTCTCCTTGACCACC TGCCTCCTAACTTGGTGTAT 857
11 TGCATTCAACCTGCTCAAACTT TCTATTGTGAACTTTGTGCGT 987
12 TGAGAAAACCCTCCTCGGTG CCATTCCCCTGCCACGAACA 393
13 GACGAGGGGGACTGGGCTTTC AGCAACAATCTATCCTACAACTT 569
14 GCTGCAGGGACAGAATGGAGTC ACGAAATTACTGGGGTCTCTGAT 608
15 CCATCATTCCATTTTACCCTCAC CTCACAGCTCTCTACTATCCA 679
16 CTGCCATCTGACCATTTCCAAT GCATCAAGGTCGTTCCCCA 302
17 CTAAAGGAGAATGGAAATGGGA CTAAGGAGCATATTTCTAAGCAG 411
18 TCCATGCTGATTTATACTGGCCT AGGGCATCAAAGACAAACGCT 397
19 CCTTAGACTTTGCTACTACGTG ATGCAAAATTCTGGCCTTGTA 491
20 GAGTGATAATAAATGACAAGCCC GTTTTCTCTCACTGTCCCATCAA 487
21 TTTTGATGGTCTTGGGATTAGC AAGTGGGAATATAAGTAAACCTC 765
22 CCTCTCTTTTTAAAGCCCTTCCC GAGTTTTCGAGGGAGTTGC 317
23 GCAAAGATGTCTGATCCCTA GGCACACACTTTTTATCCTACA 248
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Using the newly published criteria for pathogenicity of variants
[20], several lines of evidence were provided to conﬁrm the path-
ogenicity of the variant. These included 1) The inheritance pattern
2) using in silico prediction software tools (Consurf) and search
within population databases such as 1000 genomes, exome ag-
gregates and exome variant server, dbSNP and dbVar 3) The length
of the predicted truncated protein 4) Co-segregation of the variant
with deafness in the family and 5) investigation of 100 chromo-
somes of healthy ethnically-matched controls.2.5. In silico investigation
Conservation scores for each amino acid in TECTAwere acquired
from the ConSurf Server (http://conseq.tau.ac.il/). Any conservation
score greater than 1 standard deviation above the mean for the
TECTA amino acid sequence was regarded as highly conserved.2.6. Co-segregation analysis and investigation of healthy controls
The presence of homozygous variant in affected individuals its
absence in the non-affected siblings (co-segregation) of the family
and absence of the novel variant in the normal control individuals
were used to further conﬁrm the pathogenicity of the variant. For
investigation of pathogenicity of c.734G > T in exon 5 was inves-
tigated by polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) method. The restriction enzyme FspBI
(BfaI) was selected for RFLP analysis of exon 5, using Nebcutter
(version 2.0 http://tools.neb.com/NEBcutter2). After ampliﬁcation
of exon 5 in 50 (100 chromosomes) ethnically matched controls
and all available members of Avh-9 family, the amplicons were
digested and loaded on 8% PAGE at 35 mA for 2 h, followed by
visualization using silver staining. After digestion, the normal allele
should have 435 bp and 216 bp but the mutant allele should have
248, 216 and 187 bp fragments. Therefore, normal and mutant al-
leles are different for 435 bp fragment which is not digested in the
normal allele but is digested to two smaller 216 and 187 bp frag-
ments in the mutant allele.3. Results
3.1. Phenotype evaluation results
Totally, 6 Out of the 25 multiplex deaf families negative for GJB2
mutations, had moderate-to-severe phenotype and one of them
linked to DFNB21 (Ahv-9 family). Marriage in the Ahv-9 family had
occurred between second cousins (subjects 7 and 8). The pedigree
of the family Ahv-9, including three generations and with 15
members, was consistent with an autosomal recessive inheritance
pattern. Based on medical records, HL in the affected subjects was
prelingual, symmetric, and moderate to severe across all fre-
quencies but more pronounced in mid-frequencies. All heterozy-
gous carriers had normal hearing for sex and age.3.2. Molecular analysis results
After DFNB21 STR marker genotyping, haplotypes were drawn.
Homozygosity mapping was performed using six markers linked to
theDFNB21 locus on25 Iranian families negative forGJB2mutations.
Ninemembers from family Ahv-9were selected for linkage analysis.
In the Ahv-9 family, we detected homozygosity in all patients. Fig.1I
depicts the haplotype for this family. Slink, Two-point and multi-
point LOD scores were 2.77, 2.32 and 2.49, respectively. In order to
conﬁrm the result of linkage analysis and to identify the pathogenic
variant, all the 23 exons and promoter of the TECTA gene were
sequenced. The results revealed a novel variant (c.734G > A) in exon
5 of TECTA gene (the entactin G1 domain of the protein) in the pa-
tients (Fig. 1.II). This nonsense variant results in a premature stop
codon (p.W245). It leads to a truncated protein and the affected
residue is highly conserved across species (Fig.1.III). It segregated in
homozygous state in all the affected family members. The variant
was not found in 50 (100 chromosomes) ethnicallymatched healthy
controls. Several SNPs were also found which are listed in Table 3.
Based on the American College of Medical Genetics and Genomics
(ACMG)- Association for Molecular Pathology (AMP) guideline this
variant is very strong pathogenic (PVS1). (Pathogenic criterion is
weighted as very strong (PVS1), strong (PS1e4);moderate (PM1e6),
or supporting (PP1e5), and each benign criterion is weighted as
stand-alone (BA1), strong (BS1e 4), or supporting (BP1e6)).
Fig. 1. Linkage to DFNB21 and TECTAmutations. (I) Family Ahv-9 shows co-segregation of nonsyndromic recessive deafness with DFNB21 linked markers on chromosome 11q. Deaf
subjects 11, 12, 13, 14 and, 15 show homozygosity for markers linked to DFNB21. They are affected and homozygous. (II) Sequence electropherogram shows the c.734G > A mutation
found in this family. Partial TECTA sequences are shown wild type (Homozygous) (A), affected (B) and carrier (Heterozygous) (C). (III) Pathogenic variants (c.734G > A) occur at a
highly conserved position (p.W245). The corresponding DNA sequences appear in green box. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Table 3
TECTA variants identiﬁed in family Ahv-9.
Exon/Intron Nucleotide variation
(NM_138691.2)
Reference SNP
(rs) number
Exon 5 c.734G > A p.W245*
Intron 6 c.1197 þ 4 A > C e
Exon 7 c.1485A > G SNP rs536069 (A/G)
Exon 8 c. 2256 C > T SNP rs57691032 (C/T)
Exon 9 c.2805T > C SNP rs586473 (T/C)
Exon 15 c.5171G > A SNP rs526433 (G/A)
Intron 21 c. 6250 þ 314C > T e
* indicate the stop codon.
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In this study, 6 out of the 25 studied families with ARNSHL and
negative for GJB2 mutations showed moderare to severe HL. A
panel of genes including TECTA (DFNB21) was investigated in the
families (data not shown). Linkage to DFNB21was only seen in Ahv-
9 family. Upon sequencing of the gene in affected members the
homozygous c.734G > A variant was identiﬁed. This nonsense
variant (p.W245) leads to a truncated protein with only 82 resi-
dues which has lost most of its functional domains including ter-
minal part of ENTG1 domain, four von Wille brand type D (vWFD
V1, V2, V3, V4) domain and C-terminal zonapellucida (ZP) domain,
Table 4
Mutations identiﬁed in the TECTA gene and their audiometric proﬁle.
Exon Mutation Protein change Domain Time of onset Frequencies Family origin Reference
5 IVS9 þ 1 G > A p.248a ENT Prelingual All frequencies Lebanese [12]
3 c.266delT p.Leu89Arga34 ENT Prelingual Mild Iranian [23]
5 649insC e ENT Prelingua Mild Iranian [23]
5 c.651dup C p.Asn218GlnFSa31 ENT Prelingual All frequencies Iranian [14]
5 c.734G > A p.W245a ENT Prelingual All frequencies Iranian This study
9 c.2941 þ 1 G e ZA Prelingual All frequencies Iranian [12]
9e10 9.6 Kb del ZA Prelingual Mild Iranian [23]
15 c.5211 C > A p.Tyr1737a ZA Prelingual Mild Iranian [23]
15 c.5210A > G p.Y1737C C8 domain Prelingual Mild Iranian [25]
20 c.6037delG p.2018a ZP Prelingual All frequencies Pakistani [14]
21 c. 6203-6218 del p.lys 2068Arga38 ZP Prelingual All frequencies Iranian [26]
ZP: Zonapellucida domain, ZA: Zonadhesin domain.
a Protein may not be formed due to nonsense mediated decay.
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Most of the dominant TECTA (DFNA8/12) mutations been re-
ported in ZP andWF domains, which are associated with stable and
post-lingual progressive [21]. However, recessive mutations of
TECTA (DFNA21) have been reported in all domains, and are usually
linked to prelingual stable HL. Interestingly, the substituted
nucleotide found in this study (c.734G > A) resides in the ENTG1
domain which is conserved among human, rat, and chicken alpha-
tectorin (Fig. 1.III). The homology among these three orthologs is
over 70%.
Based on the ACMG-CAP guideline [20]: 1) This variant is
nonsense (p.W245), tryptophan codon replacement with stop
codon at residue 245 ((PVS1). 2) The homozygosity of this variant
conforms to the autosomal recessive pattern of inheritance (PM3).
Co-segregates with deafness: heterozygous carriers do not show
the deafness phenotype but all the homozygous individuals were
affected (PS4). 3) This variant was not found in population data-
bases including: exome sequence variant server (http://evs.gs.
washington.edu/EVS and http://browser.1000genomes.org), data-
bases SNP (http://www.ncbi.nlm.nih.gov/snp) and databases
variant (http://www.ncbi.nlm.nih.gov/dbvar) (PM2). 4) These do-
mains which are affected in this way are important because are
conserved domain (the end point of ENTG1, four von Willebrand
type D and ZP domain are omitted) (Fig. 1.III) (PM1) 5) The
c.734G > A variant is predicted to result in a premature stop codon
in the amino acid position 245 (p.W245) in the ﬁfth exon with
production of a truncated protein (PSV1). 6) It was not found in
ethnically matched healthy controls (PS4).
According to these evidences (2PVS1þ PM3þ PS4þ PM2þ PM1)
and based on the guideline ACMG-CAP [20], this variant meets the
criteria of being categorized as very strong pathogenic.
In the mouse mutant homozygous for a targeted deletion in the
ENTG1 domain of alpha-tectorin protein, the tectorial membrane
lacks its non-collagenous matrix and is detached from the surface
of the organ of Corti, leading to HL. The heterozygous mutant has a
normal tectorial membrane and normal hearing [22]. An alteration
of the a-tectorin protein is likely to disrupt the normal structure of
the extracellular matrix of the tectorial membrane, in consequence,
leading to inefﬁcient transmission of sound [23]. The frequency of
TECTA involvement (4%), we have found in the studied population
(in GJB2 negative ARNSHL families) conforms to the ﬁndings
already reported in the Iranian population. For example, TECTAwas
involved in 10 out of 242 families (4.13%) GJB2 negative ARNSHL
families [6]. So far, no reports of ARNSHL of TECTA gene (DFNB21)
has been published in the Caucasians and all reports of this mu-
tation are limited to the Middle East including Lebanon [21] and
Pakistan [14] populations (Table 4). Different studies have shown
that inactivating and non-truncating mutations of TECTA have been
associated with autosomal recessive and autosomal dominantforms of HL, respectively [24]. Our results and other former studies
emphasize that the mutations in the TECTA gene are among most
common causes of ARNSHL in the Iranian population. All mutations
found in the Iranian population are truncating loss-of-function
mutations leading to a characteristic audioproﬁle that is recogniz-
able as moderate to severe HL across all frequencies, but most
pronounced in the mid-frequency range [14,24].
In conclusion, we have identiﬁed a novel pathogenic variant in
an Iranian family. Our study, together with the data of several other
studies, suggests that in deafness diagnostics mutation analysis of
TECTA should be prioritized in the screening of families segregating
ARNSHL with moderate to severe audioproﬁle.
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